City Therapeutics: Series BDevelops next-generation RNAi therapeutics and engineering platform for multiple disease areasOct 4, 2026RoundOSCity TherapeuticsCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesEnterprise softwareHealthtechNorth AmericaSeries B